Risk of Diabetes Mellitus in Patients with Systemic Lupus Erythematosus Can be Reduced with the Use of Hydroxychloroquine
A recent study conducted by a team of researchers from Taiwan found that patients with Systemic lupus erythematosus (SLE) who are treated with a specific dose of an antimalarial drug UCQ) are less prone to develop diabetes mellitus. However, those SLE patients that are threated with high-dose glucocorticoids are…